Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2
...
28 29 30 31 32 33 34 35 36
...
99 100 Next >
Biogen/Eisai's Popular Alzheimer's Drug Leqembi Is Seeing Slow Adoption - Here's Why
Via Benzinga
Exposures Product Safety
Tickers BIIB ESALY
Best Therapists Carlton North Melbourne Delivers Psychodynamic Psychotherapy - Maple Tree Counselling Announcement
Via Press Advantage
Topics Product Recall
Exposures Legal Product Safety
ANGLE partners with AstraZeneca in groundbreaking oncology contract
Via News Direct
Exposures Product Safety
ANGLE partners with AstraZeneca in groundbreaking oncology contract
Via TheNewswire.com
Exposures Product Safety
Over-The-Counter CIC Hearing Aids With Noise Reduction Technology Updated
Via Press Release Distribution Service
Exposures Product Safety
Why Is Penny Stock HOOKIPA Pharma Trading Higher On Wednesday?
Via Benzinga
Exposures Product Safety
Tickers GILD HOOK RHHBY
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Completes Key Step in Preparation of PAX-101 for NDA Submission to FDA
Via Investor Brand Network
Exposures Product Safety
Tickers PXMD
AGC Biologics Announces Successful Completion of Production of Cancer-Specific Therapeutic Antibody Fragments with Var2 Pharmaceuticals
Via News Direct
Exposures Product Safety
FDA Approves Novartis' Lutathera As First Therapy For Pediatric Patients With Gastroenteropancreatic Neuroendocrine Tumors
Via Benzinga
Exposures Product Safety
Tickers NVS
What Analysts Are Saying About PepsiCo's Q1 Earnings?
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers GS PEP
Lisata Therapeutics advances lead asset LSTA1 for treatment of advanced solid tumors
Via TheNewswire.com
Exposures Product Safety
This Pharma Co. Kicks Off FDA Approval Process For CBD-Based Treatment Of Chronic Pain
Via Benzinga
Exposures Product Safety
Tickers CSE:INNO INNO INNPF
FDA Approves ImmunityBio's Bladder Cancer Drug, Stock Rallies
Via Benzinga
Exposures Product Safety
Tickers IBRX
FDA Rejects Approval Of Abeona Therapeutics' Skin Disorder Treatment, Shares Sink
Via Benzinga
Exposures Product Safety
Tickers ABEO
Bay Area Start-Up Brings the Power of AI to Breast Cancer Screening
Via PRLog
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Why Is Abeona Therapeutics (ABEO) Stock Down 45% Today?
Via InvestorPlace
Exposures Product Safety
Tickers ABEO HWH PEGY
Mayo Clinic Diet Survey Spotlights Important Correlation Between Weight Loss Medication and Behavioral Support Programs
Via PRUnderground
Exposures Product Safety
ROSEN, A LEADING NATIONAL FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BLUE
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers BLUE
ROSEN, A LEADING NATIONAL FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BLUE
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers BLUE
420 with CNW — FDA Boss Says DEA Doesn’t Have Reason to Delay Cannabis Rescheduling
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis Product Safety
420 with CNW — FDA Boss Says DEA Doesn’t Have Reason to Delay Cannabis Rescheduling
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis Product Safety
Tickers TSNDF TSX:TSND
InvestorNewsBreaks – NRx Pharmaceuticals Inc. Releases Pricing of Public Offering, Expected to Result in Estimated $2M
Via Investor Brand Network
Exposures Product Safety
Tickers NRXP
Mid-Cap Corcept Therapeutics Reveals Data From Hormonal Disorder Study, FDA Application Submission Expected This Quarter
Via Benzinga
Exposures Product Safety
Tickers CORT
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Zoetis Inc. Investors to Inquire About Securities Class Action Investigation - ZTS
Via NewMediaWire
Exposures Product Safety
Tickers ZTS
A Game-Changer in Weight Management with Transtek Latest Smart Scale
Via PRLog
Exposures Product Safety
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Zoetis Inc. Investors to Inquire About Securities Class Action Investigation - ZTS
Via TheNewswire.com
Exposures Product Safety
Tickers ZTS
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BLUE
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers BLUE
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BLUE
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers BLUE
ROSEN, A LONGSTANDING LAW FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BLUE
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers BLUE
ROSEN, A LONGSTANDING LAW FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BLUE
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers BLUE
< Previous 1 2
...
28 29 30 31 32 33 34 35 36
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.